Robert Raffai, Ph.D.
Assistant Adjunct Professor of Surgery
Education
-
1986-90, McGill University Faculty of Medicine, Canada, B.Sc., Biochemistry
-
1990-93, University of Montreal, Canada, Other, Biochemistry
- 1993-98, University of Ottawa, Canada, Ph.D., Biochemistry
Residencies
Postdoctoral Training
Board Certification
Program Affiliations
Clinical Expertise
Research Interests
Website LInks
Biography
Selected Publications
-
Raffai RL, Dong LM, Farese RV, Weisgraber KH. Introduction of human apolipoprotein E4 "domain interaction" into mouse apolipoprotein E. Proc Natl Acad Sci U S A. 98: 11587-91, Sep/25/2001.
-
Raffai RL, Weisgraber KH. Hypomorphic apolipoprotein E mice: a new model of conditional gene repair to examine apolipoprotein E-mediated metabolism. J Biol Chem. 277: 11064-8, Mar/29/2002.
-
Raffaï RL, Hasty AH, Wang Y, Mettler SE, Sanan DA, Linton MF, Fazio S, Weisgraber KH. Hepatocyte-derived ApoE is more effective than non-hepatocyte-derived ApoE in remnant lipoprotein clearance. J Biol Chem. 278: 11670-5, Mar/28/2003.
-
Raffai RL, Loeb SM, Weisgraber KH. Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels. Arterioscler Thromb Vasc Biol. 25: 436-41, Feb/2005.
-
Zhang S, Picard MH, Vasile E, Zhu Y, Raffai RL, Weisgraber KH, Krieger M. Diet-induced occlusive coronary atherosclerosis, myocardial infarction, cardiac dysfunction, and premature death in scavenger receptor class B type I-deficient, hypomorphic apolipoprotein ER61 mice. Circulation. 111: 3457-64, Jun/28/2005.
Media Links